Similar articles

• Economics and obesity: costing the problem or evaluating solutions?

  Roux L, Donaldson C. Roux L, et al. Obes Res. 2004 Feb;12(2):173-9. doi: 10.1038/oby.2004.23. Obes Res. 2004. PMID: 14981208 Review.
• The costs and benefits of enhanced depression care to employers.

  Wang PS, Patrick A, Avorn J, Azocar F, Ludman E, McCulloch J, Simon G, Kessler R. Wang PS, et al. Arch Gen Psychiatry. 2006 Dec;63(12):1345-53. doi: 10.1001/archpsyc.63.12.1345. Arch Gen Psychiatry. 2006. PMID: 17146009
• The role of cost effectiveness analysis in health care evaluation.

  Atherly A, Culler SD, Becker ER. Atherly A, et al. Q J Nucl Med. 2000 Jun;44(2):112-20. Q J Nucl Med. 2000. PMID: 10967622 Review.
• The economic effects of screening for obstructive airway disease: an economic analysis of the DIMCA program.

  van den Boom G, Rutten-van Mölken MP, Folgering H, van Weel C, van Schayck CP. van den Boom G, et al. Prev Med. 2000 Apr;30(4):302-8. doi: 10.1006/pmed.2000.0633. Prev Med. 2000. PMID: 10731459 Clinical Trial.
• [Economic analysis and public health. Why does one need economic evaluation applied to diabetes? What methods does one choose: cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health?].

  Triomphe A. Triomphe A. Diabete Metab. 1993 Dec;19(5 Suppl):473-6. Diabete Metab. 1993. PMID: 8206181 French.